FDB Response to Public Health England Prescribed Medicines Review - Technology Role

First DatabankCommenting on findings and recommendations from Public Health England's review into dependence and withdrawal associated with some prescribed medicines, Darren Nichols, UK managing director, FDB (First Databank), said:

"This extensive review by Public Health England underlines the challenges particularly within the primary care system to ensure that clinical guidance is effectively adhered to, with regular reviews with patients, and that prescribing is made safer.

"Its recommendation on greater prescribing transparency and accountability through increasing the availability and use of prescribing data for medicines that can cause dependence or withdrawal highlights the crucial role that technology can play in supporting GPs and other members of the primary care multi-disciplinary team.

"Although not heavily featured in the review, technology is having a big impact on primary care prescribing. Today we are working with more than 4,000 GP practices, with a patient population of 35 million, across two thirds of England’s clinical commissioning groups (CCGs) who are making significant strides in changing prescribing practice, by drawing on technology at the point of prescribing. This enables clinicians to be alerted when a prescribing decision might not comply with clinical best practice or when it might not be most appropriate for the individual patient. This has already seen thousands of GPs choose alternative medications for their patients millions of times.

"Technology like this will continue to be an essential support for GPs, and to CCGs, in helping to distil current and improved guidance around medicines examined in Public Health England’s report, and in adhering to it when appropriate. This can help to ensure greater compliance with guidance, whilst ensuring professionals remain in control of informed prescribing decisions.

"Similar technologies may also now be needed for practice pharmacists and other members of the multi-disciplinary care environment, to take an active role in identifying patient cohorts and proactively reviewing their medication."

About FDB

FDB (First Databank), part of the Hearst Health network, is the leading provider of drug knowledge that helps healthcare professionals make precise decisions. With thousands of customers worldwide, FDB enables our information system developer partners to deliver valuable, useful, and differentiated solutions. We offer four decades of experience in transforming medical knowledge into actionable, targeted, and effective solutions that help improve patient safety, operational efficiency, and healthcare outcomes.

Most Popular Now

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

The Bristol-Myers Squibb-Pfizer Alliance…

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosis of atrial fibrillation (AFib)...

Philips and Spencer Health Solutions Exp…

Building on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced...

Using Artificial Intelligence to Predict…

Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the general population, with a prevalence as high as 67%. The great majority of...

Bayer Launches LifeHub UK Focused on Art…

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar of Bayer's global network...

AI could Offer Warnings about Serious Si…

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death. Now, researchers at...

NHS Health Tech Team of the Year Named

A pioneering NHS trust has been recognised at the 2019 HTN Awards for its innovative work using InterSystems technology to help enhance care for hundreds of thousands of patients. North...

Philips and Klinikum Stuttgart Hospital …

Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and German Klinikum Stuttgart hospital, the largest provider in the region, announced they have signed a comprehensive 10-year innovation partnership...

Heartbeat Labs Hired Babylon Health's Ch…

The Berlin-based digital health platform Heartbeat Labs hired Chad Jennings as Chief Product Officer (CPO). Chad is a product and design leader with twenty years of experience at the intersection...

Combination of AI & Radiologists mor…

An artificial intelligence (AI) tool - trained on roughly a million screening mammography images - identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists, a...

Abbott and Omada Health Partner to Offer…

Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring (CGM) technology, with Omada Health's pioneering digital care...

First Entirely Digital Clinical Trial En…

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a new study. The...